XML 111 R86.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Joint Ventures (Details 1) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2013
Financial information relating to unconsolidated joint ventures operations |  |  |
Revenues | $ 219,714 | $ 193,453 | $ 142,842
Real estate depreciation and amortization | (75,492) | 69,399 | 51,830
Net loss | 175,850 | (42,667) | (36,075)
Income/(loss) from unconsolidated entities | 62,329 | (7,006) | (415)
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Real estate, net | 3,135,757 | 2,941,803 |
Total assets | 3,202,128 | 3,208,392 |
Amount due to UDR | 7,266 | 2,997 |
Third party debt | 1,614,463 | 1,493,619 |
Total liabilities | 1,717,252 | 1,770,657 |
Total equity | 1,484,876 | 1,437,735 |
Investment in and advances to unconsolidated joint ventures, net | 938,906 | 718,226 |
Equity Method of Investment Summarized Financial Information, Liabilities Sold or Held For Sale |  | 229,706 |
Equity Method of Investment Summarized Financial Information, Assets Sold or Held For Sale |  | 216,196 |
Property operating expenses | (87,500) | 72,099 | 49,390
Operating income/(loss) | 56,722 | 51,955 | 41,622
Interest expense | (64,990) | (58,591) | (45,726)
Other income/(expense) |  |  | 1
Income/(loss) from discontinued operations | 184,118 | (36,031) | (31,972)
Cash and cash equivalents | 36,480 | 32,544 |
Other assets | 29,891 | 17,849 |
Deferred Finance Costs, Net |  | 0 |
Accounts payable and accrued liabilities | 95,523 | 44,335 |
MetLife I |  |  |
Financial information relating to unconsolidated joint ventures operations |  |  |
Revenues | 541 | 727 | 691
Real estate depreciation and amortization | (818) | 2,130 | 115
Net loss | (1,203) | (33,823) | (22,433)
Income/(loss) from unconsolidated entities | (513) | (2,955) | (4,675)
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Real estate, net | 92,915 | 89,482 |
Total assets | 94,291 | 93,297 |
Amount due to UDR | 2 | 107 |
Third party debt | 0 | 0 |
Total liabilities | 397 | 5,966 |
Total equity | 93,894 | 87,331 |
Investment in and advances to unconsolidated joint ventures, net | 15,894 | 13,306 |
Equity Method of Investment Summarized Financial Information, Liabilities Sold or Held For Sale |  | 5,110 |
Equity Method of Investment Summarized Financial Information, Assets Sold or Held For Sale |  | 1,978 |
Property operating expenses | (906) | 618 | 621
Operating income/(loss) | (1,183) | (2,021) | (45)
Interest expense | 0 | 0 | 0
Other income/(expense) |  |  | 0
Income/(loss) from discontinued operations | (20) | (31,802) | (22,388)
Cash and cash equivalents | 1,202 | 1,983 |
Other assets | 174 | (146) |
Accounts payable and accrued liabilities | 395 | 749 |
MetLife II |  |  |
Financial information relating to unconsolidated joint ventures operations |  |  |
Revenues | 170,062 | 152,047 | 109,926
Real estate depreciation and amortization | (46,616) | 41,504 | 30,122
Net loss | 7,893 | 9,900 | 8,941
Income/(loss) from unconsolidated entities | 3,578 | 2,814 | 4,471
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Real estate, net | 1,942,630 | 1,986,237 |
Total assets | 1,988,311 | 2,014,420 |
Amount due to UDR | 0 | (444) |
Third party debt | 1,122,662 | 1,140,458 |
Total liabilities | 1,146,906 | 1,157,587 |
Total equity | 841,405 | 856,833 |
Investment in and advances to unconsolidated joint ventures, net | 425,230 | 431,277 |
Equity Method of Investment Summarized Financial Information, Liabilities Sold or Held For Sale |  | 0 |
Equity Method of Investment Summarized Financial Information, Assets Sold or Held For Sale |  | 0 |
Property operating expenses | (63,516) | 52,150 | 33,809
Operating income/(loss) | 59,930 | 58,393 | 45,995
Interest expense | (52,037) | (48,493) | (37,055)
Other income/(expense) |  |  | 1
Income/(loss) from discontinued operations | 0 | 0 | 0
Cash and cash equivalents | 20,767 | 15,245 |
Other assets | 24,914 | 12,938 |
Accounts payable and accrued liabilities | 24,244 | 17,573 |
Unconsolidated Joint Venture Other MetLife [Member] |  |  |
Financial information relating to unconsolidated joint ventures operations |  |  |
Revenues | 7,634 | 1,579 | 5,324
Real estate depreciation and amortization | (6,897) | 3,959 | 3,564
Net loss | (5,655) | (3,596) | (2,445)
Income/(loss) from unconsolidated entities | 6,088 | 576 | 6,224
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Real estate, net | 604,611 | 351,861 |
Total assets | 612,528 | 359,201 |
Amount due to UDR | 5,929 | 843 |
Third party debt | 201,114 | 65,408 |
Total liabilities | 269,310 | 84,102 |
Total equity | 343,218 | 275,099 |
Investment in and advances to unconsolidated joint ventures, net | 407,102 | 197,646 |
Equity Method of Investment Summarized Financial Information, Liabilities Sold or Held For Sale |  | 0 |
Equity Method of Investment Summarized Financial Information, Assets Sold or Held For Sale |  | 0 |
Property operating expenses | (3,826) | 1,122 | 3,292
Operating income/(loss) | (3,089) | (3,502) | (1,532)
Interest expense | (2,566) | (94) | (913)
Other income/(expense) |  |  | 0
Income/(loss) from discontinued operations | 0 | 0 | 0
Cash and cash equivalents | 5,996 | 6,239 |
Other assets | 1,921 | 1,101 |
Accounts payable and accrued liabilities | 62,267 | 17,851 |
Unconsolidated Joint Venture Vitruvian Park [Member] |  |  |
Financial information relating to unconsolidated joint ventures operations |  |  |
Revenues | 22,139 | 19,376 | 7,680
Real estate depreciation and amortization | (6,639) | 7,380 | 3,830
Net loss | (867) | (2,846) | (2,669)
Income/(loss) from unconsolidated entities | (3,711) | (4,068) | (2,851)
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Real estate, net | 273,897 | 278,600 |
Total assets | 283,399 | 288,418 |
Amount due to UDR | 908 | 1,960 |
Third party debt | 126,388 | 122,964 |
Total liabilities | 134,433 | 131,690 |
Total equity | 148,966 | 156,728 |
Investment in and advances to unconsolidated joint ventures, net | 73,469 | 80,302 |
Equity Method of Investment Summarized Financial Information, Liabilities Sold or Held For Sale |  | 0 |
Equity Method of Investment Summarized Financial Information, Assets Sold or Held For Sale |  | 0 |
Property operating expenses | (11,519) | 10,711 | 4,633
Operating income/(loss) | 3,981 | 1,285 | (783)
Interest expense | (4,848) | (4,131) | (1,886)
Other income/(expense) |  |  | 0
Income/(loss) from discontinued operations | 0 | 0 | 0
Cash and cash equivalents | 7,185 | 6,570 |
Other assets | 2,317 | 3,248 |
Accounts payable and accrued liabilities | 7,137 | 6,766 |
Texas JV |  |  |
Financial information relating to unconsolidated joint ventures operations |  |  |
Revenues | 0 | 0 | 0
Real estate depreciation and amortization | 0 | 0 | 0
Net loss | 184,138 | (4,229) | (9,584)
Income/(loss) from unconsolidated entities | 59,424 | (772) | (1,218)
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Real estate, net | 0 | 0 |
Total assets | 10 | 214,218 |
Amount due to UDR | 0 | 0 |
Third party debt | 0 | 0 |
Total liabilities | 0 | 224,596 |
Total equity | 10 | (10,378) |
Investment in and advances to unconsolidated joint ventures, net | 0 | (25,901) |
Equity Method of Investment Summarized Financial Information, Liabilities Sold or Held For Sale |  | 224,596 |
Equity Method of Investment Summarized Financial Information, Assets Sold or Held For Sale |  | 214,218 |
Property operating expenses | 0 | 0 | 0
Operating income/(loss) | 0 | 0 | 0
Interest expense | 0 | 0 | 0
Other income/(expense) |  |  | 0
Income/(loss) from discontinued operations | 184,138 | (4,229) | (9,584)
Cash and cash equivalents | 10 | 0 |
Other assets | 0 | 0 |
Accounts payable and accrued liabilities | 0 | 0 |
KFH |  |  |
Financial information relating to unconsolidated joint ventures operations |  |  |
Revenues | 19,338 | 19,724 | 19,221
Real estate depreciation and amortization | (14,522) | 14,426 | 14,199
Net loss | (8,456) | (8,073) | (7,885)
Income/(loss) from unconsolidated entities | (2,537) | (2,601) | (2,366)
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Real estate, net | 221,704 | 235,623 |
Total assets | 223,589 | 238,838 |
Amount due to UDR | 427 | 531 |
Third party debt | 164,299 | 164,789 |
Total liabilities | 166,206 | 166,716 |
Total equity | 57,383 | 72,122 |
Investment in and advances to unconsolidated joint ventures, net | 17,211 | 21,596 |
Equity Method of Investment Summarized Financial Information, Liabilities Sold or Held For Sale |  | 0 |
Equity Method of Investment Summarized Financial Information, Assets Sold or Held For Sale |  | 0 |
Property operating expenses | (7,733) | 7,498 | 7,035
Operating income/(loss) | (2,917) | (2,200) | (2,013)
Interest expense | (5,539) | (5,873) | (5,872)
Other income/(expense) |  |  | 0
Income/(loss) from discontinued operations | 0 | 0 | $ 0
Cash and cash equivalents | 1,320 | 2,507 |
Other assets | 565 | 708 |
Accounts payable and accrued liabilities | 1,480 | 1,396 |
Unconsolidated Joint Ventures [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Investment in and advances to unconsolidated joint ventures, net | 703,463 | 655,519 |
Scenario, Previously Reported [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Total assets |  | 3,219,250 |
Third party debt |  | 1,504,477 |
Total liabilities |  | 1,781,515 |
Other assets |  | 28,707 |
Deferred Finance Costs, Net |  | 22,686 |
Accounts payable and accrued liabilities |  | 44,335 |
Scenario, Previously Reported [Member] | MetLife I |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Total assets |  | 93,297 |
Third party debt |  | 0 |
Total liabilities |  | 5,966 |
Other assets |  | (146) |
Accounts payable and accrued liabilities |  | 749 |
Scenario, Previously Reported [Member] | MetLife II |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Total assets |  | 2,021,071 |
Third party debt |  | 1,147,109 |
Total liabilities |  | 1,164,238 |
Other assets |  | 19,589 |
Accounts payable and accrued liabilities |  | 17,573 |
Scenario, Previously Reported [Member] | Unconsolidated Joint Venture Other MetLife [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Total assets |  | 362,303 |
Third party debt |  | 68,510 |
Total liabilities |  | 87,204 |
Other assets |  | 4,203 |
Accounts payable and accrued liabilities |  | 17,851 |
Scenario, Previously Reported [Member] | Unconsolidated Joint Venture Vitruvian Park [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Total assets |  | 289,103 |
Third party debt |  | 123,649 |
Total liabilities |  | 132,375 |
Other assets |  | 3,933 |
Accounts payable and accrued liabilities |  | 6,766 |
Scenario, Previously Reported [Member] | Texas JV |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Total assets |  | 214,218 |
Third party debt |  | 0 |
Total liabilities |  | 224,596 |
Other assets |  | 0 |
Accounts payable and accrued liabilities |  | 0 |
Scenario, Previously Reported [Member] | KFH |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Total assets |  | 239,258 |
Third party debt |  | 165,209 |
Total liabilities |  | 167,136 |
Other assets |  | 1,128 |
Accounts payable and accrued liabilities |  | 1,396 |
Other Assets [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net | $ 7,900 | 4,880 |
Other Assets [Member] | MetLife I |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Other Assets [Member] | MetLife II |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (6,651) |
Other Assets [Member] | Unconsolidated Joint Venture Other MetLife [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (3,102) |
Other Assets [Member] | Unconsolidated Joint Venture Vitruvian Park [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (685) |
Other Assets [Member] | Texas JV |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Other Assets [Member] | KFH |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (420) |
Other Assets [Member] | Unconsolidated Joint Ventures [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (10,858) |
Assets, Total [Member] | MetLife I |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Assets, Total [Member] | MetLife II |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (6,651) |
Assets, Total [Member] | Unconsolidated Joint Venture Other MetLife [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (3,102) |
Assets, Total [Member] | Unconsolidated Joint Venture Vitruvian Park [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (685) |
Assets, Total [Member] | Texas JV |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Assets, Total [Member] | KFH |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (420) |
Assets, Total [Member] | Unconsolidated Joint Ventures [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (10,858) |
Debt [Member] | MetLife I |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Debt [Member] | MetLife II |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (6,651) |
Debt [Member] | Unconsolidated Joint Venture Other MetLife [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (3,102) |
Debt [Member] | Unconsolidated Joint Venture Vitruvian Park [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (685) |
Debt [Member] | Texas JV |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Debt [Member] | KFH |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (420) |
Debt [Member] | Unconsolidated Joint Ventures [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (10,858) |
Accounts Payable and Accrued Liabilities [Member] | MetLife I |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Accounts Payable and Accrued Liabilities [Member] | MetLife II |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Accounts Payable and Accrued Liabilities [Member] | Unconsolidated Joint Venture Other MetLife [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Accounts Payable and Accrued Liabilities [Member] | Unconsolidated Joint Venture Vitruvian Park [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Accounts Payable and Accrued Liabilities [Member] | Texas JV |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Accounts Payable and Accrued Liabilities [Member] | KFH |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Accounts Payable and Accrued Liabilities [Member] | Unconsolidated Joint Ventures [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Liabilities, Total [Member] | MetLife I |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Liabilities, Total [Member] | MetLife II |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (6,651) |
Liabilities, Total [Member] | Unconsolidated Joint Venture Other MetLife [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (3,102) |
Liabilities, Total [Member] | Unconsolidated Joint Venture Vitruvian Park [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (685) |
Liabilities, Total [Member] | Texas JV |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | 0 |
Liabilities, Total [Member] | KFH |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | (420) |
Liabilities, Total [Member] | Unconsolidated Joint Ventures [Member] |  |  |
Combined summary of balance sheets relating to unconsolidated joint ventures |  |  |
Deferred Finance Costs, Net |  | $ (10,858) |

X
- Definition Equity Method Investment Summarized Financial Information Accounts payable and accrued liabilities + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationAccountspayableandaccruedliabilities
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount due to UDR by an equity method investment of the entity. + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationAmountDueToRelatedParty
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of debt due to third parties by an equity method investment of the entity. + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationAmountOfDebtDueToThirdParties
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Equity method investment summarized financial information balance sheets. + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationBalanceSheetsAbstract
Namespace Prefix: | udr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity Method Investment Summarized Financial Information Cash and cash equivalents + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationCashandcashequivalents
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of depreciation and amortization reported by an equity method investment of the entity. + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationDepreciationAmortization
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity Method Investment Summarized Financial Information Income/(loss) from discontinued operations + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationIncomelossfromdiscontinuedoperations
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity Method Investment Summarized Financial Information Interest expense + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationInterestexpense
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investment Summarized Financial Information Other assets + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationOtherassets
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Method Investment Summarized Financial Information Other income/(expense) + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationOtherincomeexpense
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity Method Investment Summarized Financial Information Property Operating Expense + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationPropertyOperatingExpense
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of net real estate assets reported by an equity method investment of the entity. + References No definition available. + Details
Name: | udr_EquityMethodInvestmentSummarizedFinancialInformationRealEstateNet
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Method of Investment Summarized Financial Information, Assets Sold or Held For Sale + References No definition available. + Details
Name: | udr_EquityMethodofInvestmentSummarizedFinancialInformationAssetsSoldorHeldForSale
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Equity Method of Investment Summarized Financial Information, Liabilities Sold or Held For Sale + References No definition available. + Details
Name: | udr_EquityMethodofInvestmentSummarizedFinancialInformationLiabilitiesSoldorHeldForSale
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Equity Method of Investment Summarized Financial Information Operating income/(loss) + References No definition available. + Details
Name: | udr_EquityMethodofInvestmentSummarizedFinancialInformationOperatingincomeloss
Namespace Prefix: | udr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition For an unclassified balance sheet, the carrying amount (net of accumulated amortization) as of the balance sheet date of capitalized costs associated with the issuance of debt instruments (for example, legal, accounting, underwriting, printing, and registration costs) that will be charged against earnings over the life of the debt instruments to which such costs pertain. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 + Details
Name: | us-gaap_DeferredFinanceCostsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of assets reported by an equity method investment of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(g)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph w -Article 1 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph bb -Article 1 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph g -Subparagraph 1, 2 -Article 4 + Details
Name: | us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of equity, including noncontrolling interest, reported by an equity method investment of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.g) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 + Details
Name: | us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentSummarizedFinancialInformationIncomeStatementAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of liabilities reported by an equity method investment of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(g)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph g -Subparagraph 1, 2 -Article 4 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph w -Article 1 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph bb -Article 1 + Details
Name: | us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of net income (loss) reported by an equity method investment of the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(g)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph bb -Article 1 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph w -Article 1 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph g -Subparagraph 1, 2 -Article 4 + Details
Name: | us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of revenue from sale of goods and services reduced by sales returns, allowances, and discounts reported by an equity method investment of the entity. + References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.12) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 11 -Article 7 + Details
Name: | us-gaap_IncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=udr_UnconsolidatedJointVentureOneUDRMetLifePartnershipMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=udr_UnconsolidatedJointVentureSevenUdrMetlifeIiPartnershipMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=udr_UnconsolidatedJointVentureOtherMetLifeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=udr_UnconsolidatedJointVentureVitruvianParkMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=udr_UnconsolidatedJointVentureFourTexasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=udr_UnconsolidatedJointVentureThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=udr_UnconsolidatedJointVenturesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementScenarioAxis=us-gaap_ScenarioPreviouslyReportedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_OtherAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByAssetClassAxis=us-gaap_AssetsTotalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=us-gaap_DebtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |